Search results for MU

Phospho-PKD1/PKC mu (Ser205) Antibody, Covalab, Ref 00120414

Mu-Type Opioid Receptor (OPRM1) Antibody, Abbexa, abx328516

OPRM1 Antibody is a Rabbit Polyclonal against OPRM1.

Anti-CEACAM 5 + 6 antibody [MUS], Abcam, AB4539

Antibodies produced from cDNA: Conventional technologies usually either generate antibodies against purified proteins, or against synthetic peptides based on amino acid sequences derived from DNA sequence data. Genetic immunization involves introducing the gene in the form of a cDNA directly into an animal which translates this cDNA into protein thus stimulating an immune response against the foreign protein. Although the synthetic peptide approach is comparable in speed, the quality of antibodies generated by genetic immunization is far superior. This is because the protein is made by the immunized animal, utilzing complex cellular mechanisms that allow it to gain a native conformation. Antibodies are then generated against a native protein, such as is found in the blood or tissues of its host species. Membrane-bound or secreted proteins often create problems for conventional antibody technology because in their native form, they are often modified by glycosylation, or in some cases exist as multiple membrane-spanning proteins that are not soluble following isolation or synthesis in recombinant systems. All of these problems are avoided if the immunized animal makes the protein itself. Antibodies generated by genetic immunization have been shown to have binding affinities to the protein in the sub-nanomolar range, which are approximately 100x higher than conventionally developed antibodies and much higher than single chain antibodies. Results confirm published data for much higher avidity of sera generated by genetic immunization as compared with that gained by immunization with a corresponding recombinant protein.

Anti-mu Crystallin antibody [EPR28406-56], Abcam, AB314876

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Mu-Type Opioid Receptor (OPRM1) Antibody, Abbexa, abx216913

Mu-Type Opioid Receptor (OPRM1) Antibody is a Rabbit Polyclonal antibody for the detection of MOR.

Mu-Type Opioid Receptor (OPRM1) Antibody, Abbexa, abx338544

OPRM1 Antibody is a Rabbit Polyclonal against OPRM1.

Goat Anti-Human IgM (Mu) Antibody, Abbexa, abx120113

Goat Anti-Human IgM (mu) Antibody. IgM (mu) is a polyclonal antibody to human immunoglobulins.

Goat Anti-Human IgM (Mu) Antibody, Abbexa, abx023530

Goat Anti-Human IgM (Mu) Antibody is a Goat Polyclonal antibody against Human IgM (Mu). It is a polyclonal antibody to a human immunoglobulin.

Rabbit Anti-Mouse IgM (Mu) Antibody, Abbexa, abx023480

Rabbit Anti-Mouse IgM (Mu) Antibody is a Rabbit Polyclonal antibody against Mouse IgM. It is a polyclonal antibody to an animal immunoglobulin.

Goat Anti-Human IgM (Mu) Antibody, Abbexa, abx023532

Goat Anti-Human IgM (Mu) Antibody is a Goat Polyclonal antibody against Human IgM (Mu). It is a polyclonal antibody to a human immunoglobulin.